Biotech VC Firm ORI Capital Closes $260M Fund
Biotech venture capital firm ORI Capital announced Thursday that it has closed a $260 million fund to invest in early-stage biotech companies globally....To view the full article, register now.
Already a subscriber? Click here to view full article